Myelin Damage and Sleep: How It Disrupts Brain Rhythms

Researchers at the Netherlands Institute for Neuroscience have identified a link between myelin sheath degradation and abnormal brain activity during sleep, potentially providing a new non-invasive biomarker for neurodegenerative diseases. According to research presented at the Federation of European Neuroscience Societies (FENS) Forum 2026, myelin damage triggers epilepsy-like electrical spikes and disrupts critical oscillations exclusively … Read more

AI Model Detects Invisible Multiple Sclerosis Lesions

Researchers at the University at Buffalo have developed an artificial intelligence method to detect cortical lesions in multiple sclerosis (MS) patients using existing MRI scans. By analyzing relationships between multiple contrast images, this AI-driven approach reveals invisible gray matter damage, providing a new metric for tracking disease progression and cognitive impairment, according to a study … Read more

Virtual neurology visits match in-person care outcomes

The Shift Toward Virtual Neurology: Redefining First Impressions in Brain Health For years, the gold standard for neurological evaluations has been the in-person clinic visit. The complexity of the brain—requiring physical reflex tests and nuanced observation—made many clinicians hesitant to embrace telemedicine for first-time patients. However, recent evidence is challenging this tradition, suggesting that the … Read more

Focal white matter lesions drive grey matter inflammation and synapse loss

The Evolution of White Matter Research: From Lesion Models to Spatial Omics The landscape of neuroscience is shifting toward an era of unprecedented precision. Recent methodologies in studying white matter demyelination—specifically within the central posterior cortex (CCP), corpus callosum, and cingulum—reveal a trend toward integrating real-time functional monitoring with high-resolution genetic mapping. By utilizing sophisticated … Read more

Yaks may hold the key to treating multiple sclerosis sufferers, study says

Yaks, Myelin, and the Future of Multiple Sclerosis Treatment Scientists are turning to an unexpected source – the yak – in the search for new treatments and potential cures for multiple sclerosis (MS). A recent study published in the journal Neuron suggests that a genetic mutation found in yaks, adapted to thrive in low-oxygen environments, … Read more

Christina Applegate says she largely stays in bed because of multiple sclerosis

Christina Applegate’s Battle with MS: A Glimpse into the Future of Chronic Illness and Celebrity Advocacy Hollywood icon Christina Applegate’s candid revelations about her life with multiple sclerosis (MS) are resonating deeply with audiences and sparking a crucial conversation about chronic illness, disability, and the evolving role of celebrities in advocacy. Applegate, known for roles … Read more

Denver Public Schools moves to drop Kaiser Permanente after 50 years

Denver Public Schools and Kaiser Permanente: A Healthcare Breakup and the Future of Employee Benefits A decades-long partnership between Denver Public Schools (DPS) and Kaiser Permanente Colorado is facing a potential end, sparking concerns among educators and raising questions about the future of employee health benefits. The dispute, which has already led to a district … Read more

‘Forever chemicals’ linked to devastating, lifelong condition

The Rising Tide of “Forever Chemicals”: What the Future Holds The unsettling truth about per- and polyfluoroalkyl substances (PFAS) – often called “forever chemicals” – isn’t just about their current presence in our bodies and environment. It’s about the escalating understanding of their health impacts and the complex challenges of mitigating a problem decades in … Read more

Mixed results in using lipoic acid to treat progressive multiple sclerosis

Why Lipoic Acid Is Back in the Spotlight for Progressive Multiple Sclerosis When a 1,200‑mg daily dose of the over‑the‑counter antioxidant lipoic acid was tested in a two‑year, randomized, placebo‑controlled trial, researchers saw a modest slowdown in gray‑matter loss on MRI—yet walking speed, the study’s primary clinical endpoint, stayed unchanged. Although the results fell short … Read more

Gut bacteria mimicry can accelerate the progression of multiple sclerosis

How the Gut Microbiome Could Rewrite the Future of Multiple Sclerosis Treatment Imagine a world where a tiny, harmless gut bacterium is engineered to teach the immune system tolerance instead of attack. Recent breakthroughs from the University of Basel and the University Hospital Bonn suggest this may soon move from science fiction to clinical reality. … Read more